• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

克柔念珠菌血流感染的危险因素和结局:一项匹配的病例对照研究。

Risk factors and outcomes of Candida krusei bloodstream infection: a matched, case-control study.

机构信息

Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

出版信息

J Infect. 2013 Mar;66(3):278-84. doi: 10.1016/j.jinf.2012.11.002. Epub 2012 Nov 19.

DOI:10.1016/j.jinf.2012.11.002
PMID:23174708
Abstract

OBJECTIVES

To investigate the risk factors and outcomes associated with Candida krusei bloodstream.

METHODS

We performed a case control study of patients with C. krusei bloodstream infection at the University of Pennsylvania from 1982 to 2010. Controls were without candidemia, and matched to cases on duration of hospitalization and underlying disease.

RESULTS

We enrolled 34 cases and 114 matched controls. Most subjects (62%) had hematologic malignancies. In the multivariate model, including a priori the duration of fluconazole use (OR 1.06; 95% CI 1.00, 1.11) and days of neutropenia (OR 1.01; 95% CI 0.98, 1.13), risk factors associated with C. krusei bloodstream infection were splenectomy (OR 11.66; 95% CI 1.04, 130.64), and exposure to antimicrobials with anaerobic activity (OR 5.74; 95% CI 1.76, 18.67). Outcomes of infected patients were poor. Only 32% of case patients survived to hospital discharge, compared to 89% of controls. For 48% death was attributed to C. krusei infection.

CONCLUSIONS

C. krusei bloodstream infection occurs most commonly in neutropenic patients with hematologic malignancy. The association with prior fluconazole exposure is less marked than previously described. Splenectomy and the receipt of antimicrobials with anaerobic activity are significant risk factors. The outcome of infected patients remains poor, despite appropriate antifungal therapy.

摘要

目的

研究与克柔念珠菌血流感染相关的危险因素和结局。

方法

我们对 1982 年至 2010 年期间在宾夕法尼亚大学发生克柔念珠菌血流感染的患者进行了病例对照研究。对照组无念珠菌血症,与病例组在住院时间和基础疾病方面相匹配。

结果

我们纳入了 34 例病例和 114 例匹配的对照组。大多数患者(62%)患有血液系统恶性肿瘤。在包括氟康唑使用时间(比值比 1.06;95%置信区间 1.00,1.11)和中性粒细胞减少天数(比值比 1.01;95%置信区间 0.98,1.13)在内的多变量模型中,与克柔念珠菌血流感染相关的危险因素是脾切除术(比值比 11.66;95%置信区间 1.04,130.64)和使用具有抗厌氧菌活性的抗菌药物(比值比 5.74;95%置信区间 1.76,18.67)。感染患者的结局较差。仅有 32%的病例患者存活至出院,而对照组为 89%。48%的死亡归因于克柔念珠菌感染。

结论

克柔念珠菌血流感染最常发生于中性粒细胞减少的血液系统恶性肿瘤患者中。与氟康唑暴露的相关性不如以前描述的那么显著。脾切除术和使用具有抗厌氧菌活性的抗菌药物是显著的危险因素。尽管进行了适当的抗真菌治疗,感染患者的结局仍然较差。

相似文献

1
Risk factors and outcomes of Candida krusei bloodstream infection: a matched, case-control study.克柔念珠菌血流感染的危险因素和结局:一项匹配的病例对照研究。
J Infect. 2013 Mar;66(3):278-84. doi: 10.1016/j.jinf.2012.11.002. Epub 2012 Nov 19.
2
The changing epidemiology of invasive candidiasis: Candida glabrata and Candida krusei as the leading causes of candidemia in hematologic malignancy.侵袭性念珠菌病流行病学的变化:光滑念珠菌和克柔念珠菌成为血液系统恶性肿瘤患者念珠菌血症的主要病因。
Cancer. 2008 Jun;112(11):2493-9. doi: 10.1002/cncr.23466.
3
Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome.高危异基因骨髓移植后光滑念珠菌和克柔念珠菌血症:低剂量氟康唑预防对发病率和结局无不良影响
Bone Marrow Transplant. 2001 Nov;28(9):873-8. doi: 10.1038/sj.bmt.1703252.
4
Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry.2019例念珠菌血症患者的流行病学及转归:来自前瞻性抗真菌治疗联盟登记处的数据
Clin Infect Dis. 2009 Jun 15;48(12):1695-703. doi: 10.1086/599039.
5
Candida species bloodstream infection: epidemiology and outcome in a single institution from 1991 to 2008.念珠菌属血流感染:1991 年至 2008 年单一机构的流行病学和结局。
J Hosp Infect. 2011 Feb;77(2):157-61. doi: 10.1016/j.jhin.2010.09.026. Epub 2011 Jan 7.
6
Candidemia in a tertiary care cancer center: in vitro susceptibility and its association with outcome of initial antifungal therapy.三级医疗癌症中心的念珠菌血症:体外药敏性及其与初始抗真菌治疗结果的关联
Medicine (Baltimore). 2003 Sep;82(5):309-21. doi: 10.1097/01.md.0000091182.93122.8e.
7
Candidemia in nonneutropenic critically ill patients: risk factors for non-albicans Candida spp.非中性粒细胞减少的重症患者念珠菌血症:非白色念珠菌属的危险因素
Crit Care Med. 2008 Jul;36(7):2034-9. doi: 10.1097/CCM.0b013e3181760f42.
8
Impact of high-dose granulocyte transfusions in patients with cancer with candidemia: retrospective case-control analysis of 491 episodes of Candida species bloodstream infections.高剂量粒细胞输注对念珠菌血症癌症患者的影响:491例念珠菌属血流感染病例的回顾性病例对照分析
Cancer. 2004 Dec 15;101(12):2859-65. doi: 10.1002/cncr.20710.
9
Prior antimicrobial therapy and risk for hospital-acquired Candida glabrata and Candida krusei fungemia: a case-case-control study.既往抗菌治疗与医院获得性光滑念珠菌和克柔念珠菌血流感染风险:一项病例-病例对照研究。
Antimicrob Agents Chemother. 2005 Nov;49(11):4555-60. doi: 10.1128/AAC.49.11.4555-4560.2005.
10
Candida krusei fungaemia: antifungal susceptibility and clinical presentation of an uncommon entity during 15 years in a single general hospital.克柔念珠菌血症:一家综合医院15年间一种罕见疾病的抗真菌药敏性及临床表现
J Antimicrob Chemother. 2005 Feb;55(2):188-93. doi: 10.1093/jac/dkh532. Epub 2005 Jan 13.

引用本文的文献

1
Epidemiology, Risk Factors and Mortality of Fungal Bloodstream Infection: 14 Years of Experience at a Teaching Hospital.真菌血流感染的流行病学、危险因素及死亡率:一家教学医院14年的经验
Mycopathologia. 2025 Jun 17;190(4):55. doi: 10.1007/s11046-025-00965-3.
2
Candidaemia: A 9-Year Retrospective Analysis of Epidemiology and Antimicrobial Susceptibility in Tertiary Care Hospitals in Western China.念珠菌血症:中国西部三级医院9年流行病学及抗菌药物敏感性回顾性分析
Infect Drug Resist. 2024 Sep 5;17:3891-3900. doi: 10.2147/IDR.S477815. eCollection 2024.
3
Splenectomy for treating hepatosplenic candidiasis: Two cases and literature review suggesting its feasibility.
脾切除术治疗肝脾念珠菌病:两例病例及文献综述表明其可行性
Heliyon. 2023 Apr 3;9(4):e15114. doi: 10.1016/j.heliyon.2023.e15114. eCollection 2023 Apr.
4
Post-translational modifications confer amphotericin B resistance in isolated from a neutropenic patient.从一位中性粒细胞减少症患者中分离得到的 ,其经过翻译后修饰而获得两性霉素 B 耐药性。
Front Immunol. 2023 Mar 1;14:1148681. doi: 10.3389/fimmu.2023.1148681. eCollection 2023.
5
pericarditis presenting with cardiac tamponade and multiple organ failure after combined damage control thoracotomy and laparotomy with splenectomy in a trauma patient: Case report and review of literature.一名创伤患者在进行联合损伤控制开胸术、剖腹术及脾切除术后出现心包炎并伴有心脏压塞和多器官功能衰竭:病例报告及文献综述
Trauma Case Rep. 2021 Dec 8;37:100564. doi: 10.1016/j.tcr.2021.100564. eCollection 2022 Feb.
6
Detection of Intrinsically Resistant Candida in Mixed Samples by MALDI TOF-MS and a Modified Naïve Bayesian Classifier.基质辅助激光解析电离飞行时间质谱和改良朴素贝叶斯分类器检测混合样本中的固有耐药念珠菌。
Molecules. 2021 Jul 24;26(15):4470. doi: 10.3390/molecules26154470.
7
Species Distribution and Antifungal Susceptibility of Invasive Candidiasis: A 2016-2017 Multicenter Surveillance Study in Beijing, China.侵袭性念珠菌病的菌种分布及抗真菌药敏性:2016 - 2017年中国北京多中心监测研究
Infect Drug Resist. 2020 Jul 20;13:2443-2452. doi: 10.2147/IDR.S255843. eCollection 2020.
8
Current Aspects in the Biology, Pathogeny, and Treatment of , a Neglected Fungal Pathogen.一种被忽视的真菌病原体——[具体病原体名称未给出]在生物学、致病机制及治疗方面的当前研究进展
Infect Drug Resist. 2020 Jun 10;13:1673-1689. doi: 10.2147/IDR.S247944. eCollection 2020.
9
Antifungal Activity and Mode of Action of Miltefosine Against Clinical Isolates of .米替福新对……临床分离株的抗真菌活性及作用方式
Front Microbiol. 2020 May 19;11:854. doi: 10.3389/fmicb.2020.00854. eCollection 2020.
10
A multicenter retrospective analysis of the antifungal susceptibility patterns of Candida species and the predictive factors of mortality in South Korean patients with candidemia.韩国念珠菌血症患者念珠菌属抗真菌药敏模式及死亡预测因素的多中心回顾性分析
Medicine (Baltimore). 2020 Mar;99(11):e19494. doi: 10.1097/MD.0000000000019494.